Lescol (fluvastatin sodium) capsules, Rx
Company: Novartis
Approval Status: Approved June 1999
Treatment for: Cardiology
Areas: Cardiology/Vascular Diseases
Possible similar drugs: Lescol; Lescol XL
General Information
Other Useful Resources
Lescol has been approved as a treatment for the reduction of triglycerides and ApoB in patients with primary hypercholesterolemia and mixed dyslipidemia.
The FDA drug information shown here is licensed from Thomson CenterWatch. The information provided here is for general educational purposes only and does not constitute medical or pharmaceutical advice which should be sought from qualified medical and pharmaceutical advisers.
